Pandemic

Big Pharma's bottom line is leaving the world vulnerable to pandemics

Illustration of a math equation with money leading to a vaccination bottle
Illustration: Lazaro Gamio/Axios

Drug companies don't have much financial incentive to invest research and development dollars into new vaccines and antibiotics, leaving the world vulnerable to future pandemics.

Between the lines: The best-case scenario for these kinds of drugs is that they're lightly or never used. That doesn't sound very good to companies when their R&D dollars could alternatively go to diseases like cancer, which are much more likely to turn a sizable profit.

WHO warns of 13 emerging health threats including possible pandemics

The white logo of the World Health Organization on an azure background.
Photo: Probst/ullstein bild via Getty Images

Government leaders need to implement a "decade of change" and invest more in the key health priorities and systems to prevent global health threats over the next decade, the World Health Organization warned last week.

What's new: Climate change, infectious diseases and epidemic threats, socioeconomic inequalities, and conflicts are some of the 13 urgent challenges WHO says will imperil global health — but addressing them is "within reach" if action is taken now.